Results 21 to 30 of about 600,930 (299)
Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease
Traumatic brain injury (TBI), a growing public health problem, is a leading cause of death and disability worldwide, although its prevention measures and clinical cares are substantially improved.
Xiao-Jian Xu +5 more
doaj +1 more source
Phosphatidylserine, inflammation, and central nervous system diseases
Phosphatidylserine (PS) is an anionic phospholipid in the eukaryotic membrane and is abundant in the brain. Accumulated studies have revealed that PS is involved in the multiple functions of the brain, such as activation of membrane signaling pathways ...
Xiaohua Ma +7 more
doaj +1 more source
Isolated central nervous system Whipple disease
Background: Whipple disease (WD) is an infection caused by Tropheryma whipplei, which might present in three different forms: classical, localized, and isolated in the central nervous system (CNS). Methods: We report the result of a systematic review of the literature on WD unusually presenting with exclusively neurological symptoms, including two
Barbero-Aznarez, Pablo +9 more
openaire +3 more sources
Nanomedicine strategies for central nervous system (CNS) diseases
The blood-brain barrier (BBB) is a crucial part of brain anatomy as it is a specialized, protective barrier that ensures proper nutrient transport to the brain, ultimately leading to regulating proper brain function.
Shreya Nagri, Olivia Rice, Yupeng Chen
doaj +1 more source
BackgroundPulmonary infection caused by multidrug-resistant Acinetobacter baumannii (MDR-AB) is a common and serious complication after brain injury. There are no definitive methods for its prediction and it is usually accompanied by a poor prognosis ...
Di Wu +29 more
doaj +1 more source
It has been found that antipsychotic-naïve patients with first-episode psychosis (FEP) present with impaired hormonal regulation of appetite in terms of low leptin and high insulin levels (the adipoinsular axis).
Michał Lis +5 more
doaj +1 more source
PPARα Modulation-Based Therapy in Central Nervous System Diseases
The burden of neurodegenerative diseases in the central nervous system (CNS) is increasing globally. There are various risk factors for the development and progression of CNS diseases, such as inflammatory responses and metabolic derangements.
Deokho Lee +5 more
doaj +1 more source
Amyotrophic lateral sclerosis (ALS) is a devastating fatal neurodegenerative disease with no cure. Receptor-interacting protein kinase 1 (RIPK1) has been proposed to mediate pathogenesis of ALS.
Jun Wei +11 more
doaj +1 more source
Role of Exosomes in Central Nervous System Diseases
There are many types of intercellular communication, and extracellular vesicles are one of the important forms of this. They are released by a variety of cell types, are heterogeneous, and can roughly be divided into microvesicles and exosomes according ...
Wanying Liu +12 more
doaj +1 more source
Classification of biomarkers in central nervous system diseases
-
Gómez Hernández Fernando A. +2 more
doaj +1 more source

